OLGU SUNUMLARI
Kalça Osteonekrozu İçin Bir Tedavi Seçeneği Olarak İntra-Artiküler Ozon Enjeksiyonu
Ultrasound-Guided Intra-Articular Ozone Injection as a Therapeutic Option for Hip Osteonecrosis
Received Date : 02 Mar 2020
Accepted Date : 24 Jun 2020
Available Online : 28 Sep 2020
Mustafa Turgut YILDIZGÖRENa, Hasan OĞUZa
aDepartment of Physical Medicine and Rehabilitation, Fizikon Medical Center, Konya, TURKEY
Doi: 10.31609/jpmrs.2020-74639 - Makale Dili: EN
J PMR Sci. 2020;23(3):237-40
ÖZET
Kalça osteonekrozu, kan akımının yetersizliği nedeniyle osteositlerin
kaybına bağlı olarak gelişir. Ozon tedavisi hücre enerjisini,
oksijen metabolizmasını, antioksidan sistemi, dokulardaki mikrosirkülasyonu
olumlu yönde etkiler. Bu makalede, Hodgkin lenfoma
nedeniyle steroid kullanımına bağlı osteonekroz gelişen ve intra-artiküler
ozon enjeksiyonu ile tedavi edilen 45 yaşında bir hasta sunulmuştur.
Anahtar Kelimeler: İntraartiküler enjeksiyonlar; osteonekroz; ozon; ağrı yönetimi
ABSTRACT
Hip osteonecrosis is caused by inadequate blood supply
leading to the death of osteocytes. Ozone has a positive effect on cell
energy, oxygen metabolism, the antioxidant defense system, and microcirculation
in tissues. This case report describes a 45-year old male
who presented with bilateral hip pain due to osteonecrosis caused by
chronic steroid treatment for Hodgkin’s lymphoma, and who was
treated with intra-articular ozone.
Keywords: Intra-articular injections; osteonecrosis; ozone; pain management
REFERENCES
- Banerjee S, Issa K, Pivec R, Kapadia BH, Khanuja HS, Mont MA, et al. Osteonecrosis of the hip: treatment options and outcomes. Orthop Clin North Am. 2013;44(4):463-76. [Crossref] [PubMed]
- Tripathy SK, Goyal T, Sen RK. Management of femoral head osteonecrosis: current concepts. Indian J Orthop. 2015;49(1):28‐45. [Crossref] [PubMed] [PMC]
- Gianakos AL, Moya-Angeler J, Duggal S, Zambrana L, Fields KG, Mintz DN, et al. The efficacy of bisphosphonates with core decompression and mesenchymal stem cells compared with bisphosphonates alone in the treatment of osteonecrosis of the hip: a retrospective study. HSS J. 2016;12(2):137‐44. [Crossref] [PubMed] [PMC]
- Andriolo L, Merli G, Tobar C, Altamura SA, Kon E, Filardo G, et al. Regenerative therapies increase survivorship of avascular necrosis of the femoral head: a systematic review and meta-analysis. Int Orthop. 2018;42(7):1689-704. [Crossref] [PubMed]
- Benvenuti P. Oxygen-ozone treatment of the knee, shoulder and hip: a personal experience. Rivista Italiana di Ossigeno-Ozonoterapia 2006;5(2):135-44.
- Kizilkaya V, Uruc V, Levent A, Kanat O, Yildizgoren MT, Dogramaci Y, et al. Effectiveness of ozone therapy on tendon healing: an experimental study in generated achilles tendon injury model in rats. Journal of Hard Tissue Biology. 2018;27(4):309-14. [Crossref]
- Seyam O, Smith NL, Reid I, Gandhi J, Jiang W, Khan SA, et al. Clinical utility of ozone therapy for musculoskeletal disorders. Med Gas Res. 2018;25;8(3):103-10. [Crossref] [PubMed] [PMC]
- Re L, Mawsouf MN, Menéndez S, León OS, Sánchez GM, Hernández F. Ozone therapy: clinical and basic evidence of its therapeutic potential. Arch Med Res. 2008;39(1):17-26. [Crossref] [PubMed]
- Braidy N, Izadi M, Sureda A, Jonaidi-Jafari N, Banki A, Nabavi SF, et al. Therapeutic relevance of ozone therapy in degenerative diseases: focus on diabetes and spinal pain. J Cell Physiol. 2018;233(4):2705-14. [Crossref] [PubMed]
- Sagai M, Bocci V. Mechanisms of action involved in ozone therapy: is healing induced via a mild oxidative stress? Med Gas Res. 2011;20;1:29. [Crossref] [PubMed] [PMC]
- Bozbas GT, Sendur OF. New therapeutic aproach in rheumatoid arthritis: ozone. Int J Physiatry. 2016;2(1):007. [Crossref]
- Bocci V, Zanardi I, Travagli V. Ozone: a new therapeutic agent in vascular diseases. Am J Cardiovasc Drugs. 2011;11(2):73-82. [Crossref] [PubMed]
- Diracoglu Demirhan. [Ozone-oxygen therapies in musculoskeletal diseases]. Turk J Phys Med Rehab. 2016;62(2):183-91.
- Sen RK. Management of avascular necrosis of femoral head at pre-collapse stage. Indian J Orthop. 2009;43(1):6-16. [Crossref] [PubMed] [PMC]
